Advance in treatment strategy and immune reconstruction against HIV-1 infection

Microbiology and Immunology

Volumn 46, Issue 4, 2002, Pages 231-239

  Matsushita, Shuzo ^a   Kimura, Tetsuya ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antiviral drug resistance; Highly active antiretroviral therapy (HAART); Human immunodeficiency virus type 1 (HIV 1); Structured treatment interruption or supervised treatment interruption (STI)

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROSEI; RITONAVIR; SAQUINAVIR; STAVUDINE; STOKLIN; ZALCITABINE; ZIDOVUDINE;

DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; LONG TERM CARE; SHORT SURVEY; TREATMENT PLANNING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036239232     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2002.tb02691.x     Document Type: Short Survey

References (24)

1. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
2. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression
3. + T cell homeostasis and function in advanced HIV disease
4. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
5. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
6. The HIV-1 protease as a therapeutic target for AIDS
7. Virus replication: Target functions and events for virus-specific inhibitors
8. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
9. Perturbation of CD4+ and CD8 + T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy
10. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
11. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection
12. Reconstitution of spontaneous neutralizing antibody response against autologous HIV-1 in chronically infected patients during highly active antiretroviral therapy
13. STI vs. continuous HAART during chronic HIV infection
14. Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection
15. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
16. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
17. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
18. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes
19. HIV chemotherapy
20. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
21. Immune control of HIV-1 after early treatment of acute infection
22. HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
23. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection